Kewaunee Scientific agrees to acquire Nycom for initial $55 million

• Kewaunee Scientific agreed to acquire Nycom, the largest US laboratory dealer, for an initial base purchase price of $55 million.
• The price is subject to adjustments based on trailing 12-month or 2026 adjusted EBITDA, whichever is greater, alongside customary post-closing adjustments.
• Consideration includes a $20 million subordinated promissory note, subject to EBITDA-based adjustments, and $5 million in newly issued common stock.
• The remaining cash consideration will be funded with cash on hand and financing expected from PNC Bank at closing.
• Closing is expected in the fourth quarter of fiscal 2027, subject to customary conditions.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Kewaunee Scientific Corporation published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001193125-26-442777), on November 02, 2026, and is solely responsible for the information contained therein.